Rare diseases
Investigational molecules
Locations
Back to Bulgaria18 clinical trials in Vidin, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
BulgariaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
BulgariaStudy of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
BulgariaAsthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate
BulgariaStudy comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
BulgariaStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
BulgariaStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
BulgariaStudy Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines
BulgariaStudy on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis
BulgariaStudy on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy on the Effects of Itepekimab in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on Chronic Obstructive Pulmonary Disease (COPD) evaluating new therapeutic approaches and treatment combinations. Multiple studies assess the effectiveness of various medications in reducing exacerbations and improving lung function.
Research includes both short-term efficacy trials and extended safety monitoring programs.
Comprehensive research into Rheumatoid Arthritis treatments, including studies of biosimilar medications and novel therapeutic agents. Investigations focus on improving patient outcomes and evaluating long-term treatment effectiveness.
Multiple trials examine both established and innovative treatment approaches.
Studies examining treatments for respiratory syncytial virus (RSV) and severe asthma conditions. Research focuses on novel therapeutic approaches for managing acute respiratory infections and chronic inflammatory conditions.
Trials include both acute intervention studies and long-term treatment evaluations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
